Molecular characterization of canine parvovirus type 2 (CPV2) reveals a high prevalence of the CPV2c genotype among dogs suffering from diarrhea

Table 1 Statistical analysis of the percentage of patients with a positive CPV-2 test

Parameter	Total number of samples	CPV-2 positive number	CPV-2 positive rate (%)	CPV-2 negative number	CPV-2 negative rate (%)	X²	p	OR	95% CI
Clinical sign	n = 200	33	16.5	167	83.5			-	-
Cases with diarrhea	42	29	69.04	13	30.9	106.551	< 0.0001	11.289	(5.32–23.98)
Cases without diarrhea	158	4	2.5	154	97.4	106.551	< 0.0001	0.1314	(0.045–0.3497)
Gender	n = 200							-	-
Male	122	19	15.6	103	84.4	0.1948	0. 659	0.934	(0.5044- 1.7276)
Female	78	14	17.9	64	82.05	0.1948	0. 659	1.107	(0.5562- 2.2034)
Breed	n = 200							-	-
Pure	88	21	23.9	67	76.1	6.1846	0 .0129	1.586	(0.8565–2.9373)
Mixed	112	12	10.7	100	89.3	6.1846	0 .0129	0.6073	(0.2999–1.2298)
Age	n = 200							-	-
≤ 6 M	117	26	22.2	91	77.8	6.7003	0.0096	1.4459	(0.8145- 2.5668)
> 6 M	83	7	8.4	76	91.6	6.7003	0.0096	0.4661	(0.1973–1.101)
Vaccination status	n = 200							-	-
Vaccinated	131	6	4.6	125	95.4	39.1582	< 0.00001	0.2429	(0.0987- 0.5976)
Non vaccinated	69	27	39.1	42	60.9	39.1582	< 0.00001	3.2532	(1.7661- 5.9926)